Ident. | Authors (with country if any) | Title |
---|
000105 (2011) |
Min Shi ; Joshua Bradner ; Aneeka M. Hancock ; Kathryn A. Chung ; Joseph F. Quinn ; Elaine R. Peskind ; Douglas Galasko ; Joseph Jankovic ; Cyrus P. Zabetian ; Hojoong M. Kim ; James B. Leverenz ; Thomas J. Montine ; Carmen Ginghina ; Un Jung Kang ; Kevin C. Cain ; Yu Wang ; Jan Aasly ; David Goldstein ; Jing Zhang | Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression |
000108 (2008) |
Kenneth Marek ; Danna Jennings ; Gilles Tamagnan ; John Seibyl | Biomarkers for Parkison's disease: Tools to assess Parkinson's disease onset and progression |
000118 (2008) |
C. Warren Olanow ; Karl Kieburtz ; Anthony H. V. Schapira | Why have we failed to achieve neuroprotection in Parkinson's disease? |
000119 (2011) |
Mildred D. Gottwald ; Michael J. Aminoff | Therapies for dopaminergic‐induced dyskinesias in parkinson disease |
000126 (2008) |
Stanley Fahn | How do you treat motor complications in Parkinson's disease: Medicine, surgery, or both? |
000168 (2008) |
Christopher G. Goetz ; Murat Emre ; Bruno Dubois | Parkinson's disease dementia: Definitions, guidelines, and research perspectives in diagnosis |
000194 (1998) |
Shoulson | DATATOP: A decade of neuroprotective inquiry |
000201 (2010) |
Hsiao-Chun Cheng ; Christina M. Ulane ; Robert E. Burke | Clinical progression in Parkinson disease and the neurobiology of axons |
000205 (2008) |
Anthony H. V. Schapira ; C. Warren Olanow | Drug selection and timing of initiation of treatment in early Parkinson's disease |
000250 (2002) |
Ira Shoulson ; David Oakes ; Stanley Fahn ; Anthony Lang ; J. William Langston ; Peter Lewitt ; C. Warren Olanow ; John B. Penney ; Caroline Tanner ; Karl Kieburtz ; Alice Rudolph | Impact of sustained deprenyl (selegiline) in levodopa‐treated Parkinson's disease: A randomized placebo‐controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial |
000269 (2002) |
Gilberto Levy ; Nicole Schupf ; Ming-Xin Tang ; Lucien J. Cote ; Elan D. Louis ; Helen Mejia ; Yaakov Stern ; Karen Marder | Combined effect of age and severity on the risk of dementia in Parkinson's disease |
000271 (2011) |
Ronald B. Postuma ; Jean-François Gagnon ; Mélanie Vendette ; Catherine Desjardins ; Jacques Y. Montplaisir | Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder |
000274 (1998) |
Poewe ; G. K. Wenning | The natural history of parkinson's disease |
000284 (2009) |
Matthias Elstner ; Christopher M. Morris ; Katharina Heim ; Peter Lichtner ; Andreas Bender ; Divya Mehta ; Claudia Schulte ; Manu Sharma ; Gavin Hudson ; Stefano Goldwurm ; Alessandro Giovanetti ; Massimo Zeviani ; David J. Burn ; Ian G. Mckeith ; Robert H. Perry ; E. Jaros ; Rejko Krüger ; H. Rich Wichmann ; Stefan Schreiber ; Harry Campbell ; James F. Wilson ; Alan F. Wright ; Malcolm Dunlop ; Giorgio Pistis ; Daniela Toniolo ; Patrick F. Chinnery ; Thomas Gasser ; Thomas Klopstock ; Thomas Meitinger ; Holger Prokisch ; Douglass M. Turnbull | Single‐cell expression profiling of dopaminergic neurons combined with association analysis identifies pyridoxal kinase as Parkinson's disease gene |
000294 (2011) |
Rick C. Helmich ; Marcel J. R. Janssen ; Wim J. G. Oyen ; Bastiaan R. Bloem ; Ivan Toni | Pallidal dysfunction drives a cerebellothalamic circuit into Parkinson tremor |
000310 (1986) |
Whitehouse | The concept of subcortical and cortical dementia: Another look |
000316 (2011) |
Alice S. Chen-Plotkin ; William T. Hu ; Andrew Siderowf ; Daniel Weintraub ; Rachel Goldmann Gross ; Howard I. Hurtig ; Sharon X. Xie ; Steven E. Arnold ; Murray Grossman ; Christopher M. Clark ; Leslie M. Shaw ; Leo Mccluskey ; Lauren Elman ; Vivianna M. Van Deerlin ; Virginia M. Lee ; Holly Soares ; John Q. Trojanowski | Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease |
000322 (2008) |
Owen A. Ross ; Adam T. Braithwaite ; Lisa M. Skipper ; Jennifer Kachergus ; Mary M. Hulihan ; Frank A. Middleton ; Kenya Nishioka ; Julia Fuchs ; Thomas Gasser ; Demetrius M. Maraganore ; Charles H. Adler ; Lydie Larvor ; Marie-Christine Chartier-Harlin ; Christer Nilsson ; J. William Langston ; Katrina Gwinn ; Nobutaka Hattori ; Matthew J. Farrer | Genomic investigation of α‐synuclein multiplication and parkinsonism |
000324 (2010) |
Fabrizio Stocchi ; Olivier Rascol ; Karl Kieburtz ; Werner Poewe ; Joseph Jankovic ; Eduardo Tolosa ; Paulo Barone ; Anthony E. Lang ; C. Warren Olanow | Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE‐PD study |
000353 (2009) |
Alexis Elbaz ; Jacqueline Clavel ; Paul J. Rathouz ; Frédéric Moisan ; Jean-Philippe Galanaud ; Bernard Delemotte ; Annick Alpérovitch ; Christophe Tzourio | Professional exposure to pesticides and Parkinson disease |
000369 (2011) |
Raúl De La Fuente-Fernández ; Michael Schulzer ; Lisa Kuramoto ; Jacquelyn Cragg ; Nandhagopal Ramachandiran ; Wing L. Au ; Edwin Mak ; Jess Mckenzie ; Siobhan Mccormick ; Vesna Sossi ; Thomas J. Ruth ; Chong S. Lee ; Donald B. Calne ; A. Jon Stoessl | Age‐specific progression of nigrostriatal dysfunction in Parkinson's disease |
000380 (2008) |
W. R. Wayne Martin ; Marguerite Wieler ; A. Jon Stoessl ; Michael Schulzer | Dihydrotetrabenazine positron emission tomography imaging in early, untreated Parkinson's disease |
000381 (2008) |
Tanya Simuni ; Kapil Sethi | Nonmotor manifestations of Parkinson's disease |
000393 (2006) |
Shannon K. Mcdonnell ; Daniel J. Schaid ; Alexis Elbaz ; Kari J. Strain ; James H. Bower ; J. Eric Ahlskog ; Demetrius M. Maraganore ; Walter A. Rocca | Complex segregation analysis of Parkinson's disease: The Mayo Clinic Family Study |
000436 (2010) |
Beate Ritz ; Shannon L. Rhodes ; Lei Qian ; Eva Schernhammer ; J Rgen H. Olsen ; S Ren Friis | L‐type calcium channel blockers and Parkinson disease in Denmark |
000462 (2008) |
Peter Jenner | Functional models of Parkinson's disease: A valuable tool in the development of novel therapies |
000492 (1987) |
Diamond ; Charles H. Marchkham ; Marchgaret M. Hoehn ; Fletcher H. Mcdowell ; Manfred D. Muenter | Multi‐center study of Parkinson mortality with early versus later dopa treatment |
000499 (2006) |
Wendy R. Galpern ; Anthony E. Lang | Interface between tauopathies and synucleinopathies: A tale of two proteins |
000505 (2010) |
Donald L. Bliwise ; Lynn Marie Trotti ; Sophia A. Greer ; Jorge J. Juncos ; David B. Rye | Phasic muscle activity in sleep and clinical features of Parkinson disease |
000509 (1996) |
Kieburtz | Effect of lazabemide on the progression of disability in early Parkinson's disease |
000539 (2008) |
Daniel Weintraub | Dopamine and impulse control disorders in Parkinson's disease |
000570 (2011) |
Valerie Voon ; Mandy Sohr ; Anthony E. Lang ; Marc N. Potenza ; Andrew D. Siderowf ; Jacqueline Whetteckey ; Daniel Weintraub ; Glen R. Wunderlich ; Mark Stacy | Impulse control disorders in parkinson disease: A multicenter case–control study |
000608 (1983) |
Lieberman ; Govindan Gopinathan ; Andreas Neophytides ; Morton Leibowitz ; Russell Walker ; Emil Hiesiger | Bromocriptine and lisuride in Parkinson disease |
000621 (2007) |
An Goris ; Caroline H. Williams-Gray ; Graeme R. Clark ; Thomas Foltynie ; Simon J. G. Lewis ; Joanne Brown ; Maria Ban ; Maria G. Spillantini ; Alastair Compston ; David J. Burn ; Patrick F. Chinnery ; Roger A. Barker ; Stephen J. Sawcer | Tau and α‐synuclein in susceptibility to, and dementia in, Parkinson's disease |
000644 (2011) |
J. Simon Lunn ; Stacey A. Sakowski ; Junguk Hur ; Eva L. Feldman | Stem cell technology for neurodegenerative diseases |
000647 (1978) |
Diamond ; Charles H. Markham ; Leo J. Treciokas | A double‐blind comparison of levodopa, madopa, and sinemet in Parkinson disease |
000671 (2006) |
Dana B. Hancock ; Eden R. Martin ; Kenichiro Fujiwara ; Mark A. Stacy ; Burton L. Scott ; Jeffrey M. Stajich ; Rita Jewett ; Yi-Ju Li ; Michael A. Hauser ; Jeffery M. Vance ; William K. Scott | NOS2A and the modulating effect of cigarette smoking in Parkinson's disease |
000686 (1998) |
Shoulson | Mortality in DATATOP: A Multicenter trial in early Parkinson's disease |
000705 (2010) |
Cory Toth ; Kim Breithaupt ; Shaohua Ge ; Yanjun Duan ; Joan M. Terris ; Anita Thiessen ; Samuel Wiebe ; Douglas W. Zochodne ; Oksana Suchowersky | Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease |
000706 (1992) |
Fahn ; Gerald Cohen | The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it |
000709 (1980) |
Boller ; Tomohiko Mizutani ; Uros Roessmann ; Pierluigi Gambetti | Parkinson disease, dementia, and alzheimer disease: Clinicopathological correlations |
000715 (2003) |
Sofia A. Oliveira ; William K. Scott ; Eden R. Martin ; Martha A. Nance ; Ray L. Watts ; Jean P. Hubble ; William C. Koller ; Rajesh Pahwa ; Matthew B. Stern ; Bradley C. Hiner ; William G. Ondo ; Fred H. Allen Jr. ; Burton L. Scott ; Christopher G. Goetz ; Gary W. Small ; Frank Mastaglia ; Jeffrey M. Stajich ; Fengyu Zhang ; Michael W. Booze ; Michelle P. Winn ; Lefkos T. Middleton ; Jonathan L. Haines ; Margaret A. Pericak-Vance ; Jeffery M. Vance | Parkin mutations and susceptibility alleles in late‐onset Parkinson's disease |
000748 (2006) |
Benoit I. Giasson ; Jason P. Covy ; Nancy M. Bonini ; Howard I. Hurtig ; Matthew J. Farrer ; John Q. Trojanowski ; Vivianna M. Van Deerlin | Biochemical and pathological characterization of Lrrk2 |
000768 (2011) |
Michael A. Van Es ; Helenius J. Schelhaas ; Paul W. J. Van Vught ; Nicola Ticozzi ; Peter M. Andersen ; Ewout J. N. Groen ; Claudia Schulte ; Hylke M. Blauw ; Max Koppers ; Frank P. Diekstra ; Katsumi Fumoto ; Ashley Lyn Leclerc ; Pamela Keagle ; Bastiaan R. Bloem ; Hans Scheffer ; Bart F. L. Van Nuenen ; Marka Van Blitterswijk ; Wouter Van Rheenen ; Anne-Marie Wills ; Patrick P. Lowe ; Guo-Fu Hu ; Wenhao Yu ; Hiroko Kishikawa ; David Wu ; Rebecca D. Folkerth ; Claudio Mariani ; Stefano Goldwurm ; Gianni Pezzoli ; Philip Van Damme ; Robin Lemmens ; Caroline Dahlberg ; Anna Birve ; Rubén Fernández-Santiago ; Stefan Waibel ; Christine Klein ; Markus Weber ; Anneke J. Van Der Kooi ; Marianne De Visser ; Dagmar Verbaan ; Jacobus J. Van Hilten ; Peter Heutink ; Eric A. M. Hennekam ; Edwin Cuppen ; Daniela Berg ; Robert H. Brown Jr ; Vincenzo Silani ; Thomas Gasser ; Albert C. Ludolph ; Wim Robberecht ; Roel A. Ophoff ; Jan H. Veldink ; R. Jeroen Pasterkamp ; Paul I. W. De Bakker ; John E. Landers ; Bart P. Van De Warrenburg ; Leonard H. Van Den Berg | Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis |
000773 (1982) |
Edward C. Hansch ; Syndulko ; Stanley N. Cohen ; Zev I. Goldberg ; Alfred R. Potvin ; Wallace W. Tourtellotte | Cognition in Parkinson disease: An event‐related potential perspective |
000827 (2007) |
Denise M. Kay ; Dawn Moran ; Lina Moses ; Parvoneh Poorkaj ; Cyrus P. Zabetian ; John Nutt ; Stewart A. Factor ; Chang-En Yu ; Jennifer S. Montimurro ; Robert G. Keefe ; Gerard D. Schellenberg ; Haydeh Payami | Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patients |
000837 (2005) |
Peter P. Pramstaller ; Michael G. Schlossmacher ; Thomas S. Jacques ; Francesco Scaravilli ; Cordula Eskelson ; Imelda Pepivani ; Katja Hedrich ; Susanna Adel ; Melissa Gonzales-Mcneal ; Rüdiger Hilker ; Patricia L. Kramer ; Christine Klein | Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers |
000842 (2003) |
Fabrizio Stocchi ; C. Warren Olanow | Neuroprotection in Parkinson's disease: Clinical trials |
000861 (1997) |
| Entacapone improves motor fluctuations in levodopa‐ treated Parkinson's disease patients |
000878 (2008) |
G. Webster Ross ; Helen Petrovitch ; Robert D. Abbott ; Caroline M. Tanner ; Jordan Popper ; Kamal Masaki ; Lenore Launer ; Lon R. White | Association of olfactory dysfunction with risk for future Parkinson's disease |
000922 (1981) |
Stanley H. Appel | A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and alzheimer disease |